Angelini Chemicals
-
-
Since 1967 into API CDMO business
-
We help to make your Molecules
-
Put your chemistry in our hands
News & publications
-
Pubblicato:
HIGH-POTENT API: Strategy and Legacy
The pharmaceutical landscape is continuously evolving, driven by innovation in drug development and the growing demand for targeted therapies. High-potency active pharmaceutical ingredients (HPAPIs) have emerged as crucial components in treating diseases such as cancer and autoimmune disorders. Recognizing the increasing importance of HPAPIs, our company has strategically diversified into their production, and our extensive experience in producing traditional APIs provides a foundation for success in this new venture.
-
Pubblicato:
Angelini Pharma earns EcoVadis Gold Medal, ranking in the top 5% globally
Angelini Pharma has earned the EcoVadis Gold Medal, marking an important step forward in our sustainability journey.
The recognition places us in the top 5% of companies assessed by EcoVadis worldwide over the previous 12 months, corresponding to the 95th percentile or above. Our overall EcoVadis score also increased from 69 to 82, building on the Silver Medal achieved in the previous assessment.
-
Pubblicato:
APIs, HPAPIs and the Future of Pharmaceutical Development
The pharmaceutical industry is undergoing a deep transformation driven by scientific innovation, regulatory evolution, and technological progress. At the center of this transformation are active pharmaceutical ingredients (APIs), the substances responsible for the therapeutic effect of a medicinal product.
-
Pubblicato:
CPHI Europe 2026
CPHI Milan is the most important pharmaceutical event worldwide and represents each stage of the pharmaceutical supply chain.
Who we are
-
What we do
Since 1967, branded and generic pharmaceutical industries have been relying on Angelini Pharma-API Business Unit to accelerate their R&D portfolio to the pharmaceutical market.
-
Our Business Model
Since its foundation, chemistry, technology and people set the ground for Angelini Pharma API Business Unit. Angelini culture remains true to these values and define how we conduct our business today.
-
Our plant
With over 50 years of experience in pharmaceuticals manufacturing industry, Angelini Pharma-API Business Unit is one of the major API manufacturers in Italy and Europe.
Our services
-
Custom synthesis
Angelini Pharma-API Business Unit helps pharmaceutical customers bringing new brand drugs to market.
-
Project management
Angelini Pharma API Business Unit offers a dedicated project team to coordinate every aspect of chemical development for your small molecules.
-
Supply chain management
Angelini Pharma- API Business Unit recognizes the importance of Supply Chain Management and its role to support Company and Customer competitiveness.
-
Regulatory support
As a CDMO involved in the manufacture of RSMs and APIs, Angelini Pharma- API Business Unit constantly reviews regulatory developments in all relevant pharmaceutical markets.
R&D
-
API expertise
Angelini’s strength in API Research & Development is proven by being the partner of choice for large pharma and smaller biotech companies seeking integrated drug development solutions to accelerate R&D pipelines from bench to market.
-
Kilo-lab
Angelini R&D team can rapidly develop scalable, robust and cost-effective chemical synthesis that can be readily transferred to our kilo-labs either as a proof of concept study, or for scale-up and delivery of material to support your early clinical supply as well as small volume API and HPAPI. -
Reaction Technology
Angelini Pharma-API Business Unit has a long tradition in API industry and has built up a comprehensive capability and expertise to carry out complex and hazardous operations for the manufacturing API and HPAPI, safely, in accordance with cGMP standards and customer quality expectations.
-
Analytical development equipment
The API chemical development is backed-up by comprehensive analytical development capabilities utilizing state-of-the-art R&D labs.